These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28703718)

  • 1. Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics.
    Murias S; Magallares L; Albizuri F; Pascual-Salcedo D; Dreesen E; Mulleman D
    Ther Drug Monit; 2017 Aug; 39(4):370-378. PubMed ID: 28703718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis.
    Medina F; Plasencia C; Goupille P; Ternant D; Balsa A; Mulleman D
    Ther Drug Monit; 2017 Aug; 39(4):364-369. PubMed ID: 28700520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.
    Carman N; Mack DR; Benchimol EI
    Curr Gastroenterol Rep; 2018 Apr; 20(5):18. PubMed ID: 29623442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Practice of Therapeutic Drug Monitoring of Biopharmaceuticals in Psoriasis Patients.
    Hermans C; Herranz P; Segaert S; Gils A
    Ther Drug Monit; 2017 Aug; 39(4):356-359. PubMed ID: 28379894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Bowel Disease.
    Detrez I; Van Stappen T; Martín Arranz MD; Papamichael K; Gils A
    Ther Drug Monit; 2017 Aug; 39(4):344-349. PubMed ID: 28328760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases.
    Papamichael K; Vogelzang EH; Lambert J; Wolbink G; Cheifetz AS
    Expert Rev Clin Immunol; 2019 Aug; 15(8):837-848. PubMed ID: 31180729
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease.
    Hemperly A; Sandborn WJ; Vande Casteele N
    Inflamm Bowel Dis; 2018 Nov; 24(12):2527-2542. PubMed ID: 29788338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab.
    Llinares-Tello F; de Salazar JR; Gallego JM; Soler GS; Ramírez CS; Heredia ES; García JM
    Clin Chem Lab Med; 2012 Oct; 50(10):1845-7. PubMed ID: 23089717
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic Drug Monitoring in Pediatric IBD: Current Application and Future Perspectives.
    Lega S; Bramuzzo M; Dubinsky MC
    Curr Med Chem; 2018; 25(24):2840-2854. PubMed ID: 28901267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis.
    Medina F; Plasencia C; Goupille P; Paintaud G; Balsa A; Mulleman D
    Ther Drug Monit; 2017 Aug; 39(4):360-363. PubMed ID: 28379895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease: An Answer to Optimized Treatment?
    Hoseyni H; Xu Y; Zhou H
    J Clin Pharmacol; 2018 Jul; 58(7):864-876. PubMed ID: 29462502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?
    Samaan MA; Arkir Z; Ahmad T; Irving PM
    Expert Opin Biol Ther; 2018 Dec; 18(12):1271-1279. PubMed ID: 30339466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant associations of antidrug antibody levels with serum drug trough levels and therapeutic response of adalimumab and etanercept treatment in rheumatoid arthritis.
    Chen DY; Chen YM; Tsai WC; Tseng JC; Chen YH; Hsieh CW; Hung WT; Lan JL
    Ann Rheum Dis; 2015 Mar; 74(3):e16. PubMed ID: 24442879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts.
    den Broeder AA; van Herwaarden N; van den Bemt BJF
    Curr Opin Rheumatol; 2018 May; 30(3):266-275. PubMed ID: 29389829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
    Bonafede M; Joseph GJ; Princic N; Harrison DJ
    J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing biological treatment in rheumatoid arthritis with the aid of therapeutic drug monitoring.
    Eng GP
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
    Syversen SW; Goll GL; Jørgensen KK; Sandanger Ø; Sexton J; Olsen IC; Gehin JE; Warren DJ; Brun MK; Klaasen RA; Karlsen LN; Noraberg G; Zettel C; Ljoså MKA; Haugen AJ; Njålla RJ; Bruun TJ; Seeberg KA; Michelsen B; Strand EK; Skorpe S; Blomgren IM; Bragnes YH; Dotterud CK; Thune T; Ystrøm CM; Torp R; Mielnik P; Mørk C; Kvien TK; Jahnsen J; Bolstad N; Haavardsholm EA
    JAMA; 2021 May; 325(17):1744-1754. PubMed ID: 33944876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of biologics to reduce treatment failure in inflammatory bowel diseases.
    Bourchany A; Gilletta De Saint-Joseph C; Breton A; Barreau F; Mas E
    Curr Opin Pharmacol; 2020 Oct; 54():51-58. PubMed ID: 32947075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.
    Yun H; Xie F; Delzell E; Levitan EB; Chen L; Lewis JD; Saag KG; Beukelman T; Winthrop KL; Baddley JW; Curtis JR
    Arthritis Rheumatol; 2016 Jan; 68(1):56-66. PubMed ID: 26315675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug monitoring of biologics in inflammatory bowel disease.
    Eser A; Primas C; Reinisch W
    Curr Opin Gastroenterol; 2013 Jul; 29(4):391-6. PubMed ID: 23703367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.